664. Are Thousands of Medical Cures Hiding in Plain Sight?
This episode of Freakonomics Radio, guest-hosted by economist Steve Levitt, explores the untapped potential of repurposing existing drugs to treat rare and deadly diseases, highlighting both the scientific promise and the broken economic incentives that prevent widespread adoption. The st
Sign up to read the full summary
Free AI-powered recaps of every episode, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.
Guest
David Fajgenbaum
narrative on Freakonomics Radio
Mentions
Books, people, and resources mentioned in this episode.
People
Companies
Products & Tools
Research & Papers
Topics
Listen to This Episode
More from Freakonomics Radio
Are You Really Allergic to Penicillin? (Update)
678. Who Gets to Choose a “Good Death”?
All You Need Is Nudge (Update)
671. Why Has There Been So Little Progress on Alzheimer’s Disease?
The World Is (Still) Drowning in Sludge
666. This Is How Progress Happens
Related episodes
From other shows on similar topics.
#374 - "Doctors Are Legally BANNED From Telling You This" - Pharma Whistleblower | Brigham Buhler
Danny Jones Podcast
Drug Story: Ivermectin
99% Invisible
Longer Life: What Does Science Say?
On with Kara Swisher
Ozempic for All?
The Daily
People are running their own experiments with GLP-1s — with stunning results
Apple News Today
D.A. Wallach Explains Why Biotech VC Is So Different
Odd Lots
Get summaries like this every morning.
Free AI-powered recaps of Freakonomics Radio and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.